"*Nationwide studies refer to those offered in every US State." Nutritional Intervention to Prevent Diabetes (TrialNet)Who can participate?This study is no longer recruiting patients. Pregnant women in their third trimester of pregnancy and infants 6 months of age or younger were eligible to enroll if there was a family history of type 1 diabetes.What is this study? This study is based on observations that children who have received more omega-3 fatty acid—-either in the womb or during the first year of life—-have a lower risk of developing type 1 diabetes. This pilot study is helping to inform the development of a full-scale study to test whether omega-3 fatty acids can protect children from developing type 1 diabetes. The enrolled infants or pregnant women will randomly be assigned to one of two groups: (1) daily omega-3 fatty acid supplements (in the form of docosahexaenoic acid, or DHA); or (2) placebo (no supplements).Why is it being done? This study is a feasibility study to determine if a full-scale omega-3 fatty acid supplementation study will be implemented.If I enroll in this study, what do I have to do? Pregnant women or infants will be randomized to one of the two study groups: DHA supplementation (this is the intervention) or control (this is the placebo). The DHA to be used in this trial is produced from algae, not from fish oil, so there is no risk of mercury or pesticide contamination.Can I participate in other studies if I participate in this one? You cannot participate in other studies while participating in this study.How can I learn more? Please call the toll free number below or visit the TrialNet website.
*Nationwide studies refer to those offered in every US State. |